Title : Determination of 5-fluorouracil and tegafur in tear fluid of patients treated with oral fluoropyrimidine anticancer agent, S-1.

Pub. Date : 2018 Jul

PMID : 29931401






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Determination of 5-fluorouracil and tegafur in tear fluid of patients treated with oral fluoropyrimidine anticancer agent, S-1. Tegafur proteasome 26S subunit, non-ATPase 1 Homo sapiens
2 PURPOSE: To establish a method for the measurement of 5-fluorouracil (5-FU), and tegafur (FT) in tear samples from patients treated with oral fluoropyrimidine anticancer agent S-1. Tegafur proteasome 26S subunit, non-ATPase 1 Homo sapiens
3 PURPOSE: To establish a method for the measurement of 5-fluorouracil (5-FU), and tegafur (FT) in tear samples from patients treated with oral fluoropyrimidine anticancer agent S-1. Tegafur proteasome 26S subunit, non-ATPase 1 Homo sapiens
4 The mean concentrations of 5-FU and FT in tears during S-1 treatment were 0.17 +- 0.11 and 1.94 +- 0.71 mug/mL, respectively. Tegafur proteasome 26S subunit, non-ATPase 1 Homo sapiens